Cats with asthma

Article source Link

Article source Link

Douglas Krafte, Ph.D., VP of Biology and Scientific Affairs at Icagen, stated, 'Icagen is investigating various cell types which are keys to the complex pathophysiology of asthma. The literature supports the importance of various immune system and airway cells in the development of asthma. The potassium ion channel KCa3.1 is present in many of these cell types, including mast cells, as shown in these data. We look forward to continuing to explore the roles of this target and the potential of senicapoc in support of our clinical asthma program. For many patients, asthma is still inadequately controlled by currently available treatments. As such, senicapoc represents a potential new oral therapy with an innovative mechanistic approach for the treatment of this disease.'

NRC immunologist receives funding to research asthma drug Charlottetown, PEI, and Montreal, QC - Merck Frosst Canada is funding an asthma-related project initiated by the National Research Council of Canada (NRC). Earlier this year, Merck Frosst approved a proposal by a Charlottetown-based immunologist at the NRC Institute for Nutrisciences and Health. Under the direction of Dr Marianna Kulka, the pre-clinical pediatric asthma study is expected to wrap up by December 2008.
'NRC's relationship with Merck Frosst is an example of our strategy to unite public and private research strengths as we put science to work for Canada,' says Dr Pierre Coulombe, NRC President. 'By teaming up with biopharmaceutical leaders like Merck Frosst, NRC can further innovate to help improve human health, including the health of Canadian children.'
More than half a million Canadian children have asthma

Asthma bronchial

How to snowboard

Woodwork magazine

Fine woodworking magazine

Skywatcher telescope

Telescope for kids

Rent to buy

Snowboard packages

Studio to rent

Magazine waiting room